Effects of alpha 2-adrenoceptor agonists dexmedetomidine and guanfacine on morphine analgesia and tolerance in rats

References

• Liu JG, Anand KJ. Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Rev. 2001;38:1–19.
   PubMed Web of Science ®Google Scholar
• Liu W, Wang CH, Cui Y, Mo LQ, Zhi JL, Sun SN, Inhibition of neuronal nitric oxide synthase antagonizes morphine antinociceptive tolerance by decreasing activation of p38MAPK in the spinal microglia. Neurosci Lett. 2006;410:174–7.
   PubMed Web of Science ®Google Scholar
• Joharchi K, Jorjani M. The role of nitric oxide in diabetes-induced changes of morphine tolerance in rats. Eur J Pharmacol. 2007;570:66–71.
   Google Scholar
• Ozdemir E, Bagcivan I, Durmus N, Altun A, Gursoy S. The nitric oxide–cGMP signaling pathway plays a significant role in tolerance to the analgesic effect of morphine. Can J Physiol Pharmacol. 2011;89:89–95.
   PubMed Web of Science ®Google Scholar
• Ossipov MH, Lozito R, Messineo E, Green J, Harris S, Lloyd P. Spinal antinociceptive synergy between clonidine and morphine, U69593, and DPDPE: isobolographic analysis. Life Sci. 1990;47:71–6.
   Google Scholar
• Ozdogan UK, Lahdesmaki J, Scheinin M. Influence of prazosin and clonidine on morphine analgesia, tolerance and withdrawal in mice. Eur J Pharmacol. 2003;460:127–34.
   Google Scholar
• Roerig SC, Lei S, Kitto K, Hylden JK, Wilcox GL. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors. J Pharmacol Exp Ther. 1992;262:365–74.
   Google Scholar
• Iglesias V, Alguacil LF, Alamo C, Cuenca E. Effects of yohimbine on morphine analgesia and physical dependence in the rat. Eur J Pharmacol. 1992;211:35–8.
   Google Scholar
• Lakhlani PP, MacMillan LB, Guo TZ, McCool BA, Lovinger DM, Maze M, Substitution of a mutant alpha2a-adrenergic receptor via hit and run gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci USA. 1997;94:9950–5.
   PubMed Web of Science ®Google Scholar
• Stone LS, MacMillan LB, Kitto KF, Limbird LE, Wilcox GL. The alpha(2A) adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. J Neurosci. 1997;17:7157–65.
   PubMed Web of Science ®Google Scholar
• Hunter JC, Fontana DJ, Hedley LR, Jasper JR, Lewis R, Link RE, Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol. 1997;122:1339–44.
   PubMed Web of Science ®Google Scholar
• Lahdesmaki J, Sallinen J, MacDonald E, Sirvif J, Scheinin M. Alpha2-adrenergic drug effects on brain monoamines, locomotion, and body temperature are largely abolished in mice lacking the alpha2A-adrenoceptor subtype. Neuropharmacology. 2003;44:882–92.
   Google Scholar
• Guneli E, Yavasoglu NUK, Apaydin S, Uyar M, Uyar M. Analysis of the antinociceptive effect of systemic administration of tramadol and dexmedetomidine combination on rat models of acute and neuropathic pain. Pharmacol Biochem Behav. 2007;88:9–17.
   Google Scholar
• Scheinin B, Lindgren L, Randell T, Scheinin H, Scheinin M. Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and perioperative fentanyl. Br J Anaesth. 1992;68:126–31.
   PubMed Web of Science ®Google Scholar
• Bhana N, Goa, KL, McClellan KJ. Dexmedetomidine. Drugs. 2000;59:263–8.
   PubMed Web of Science ®Google Scholar
• MacDonald E, Scheinin H, Scheinin M. Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative. Eur J Pharmacol. 1988;158:119–27.
   PubMed Web of Science ®Google Scholar
• Arnsten AF, Leslie FM. Behavioral and receptor binding analysis of the alpha 2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-yl amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an alpha 2-adrenoceptor subtype. Neuropharmacology. 1991;30:1279–89.
   Google Scholar
• Milanes MV, Laorden ML. Changes in catecholaminergic pathways innervating the rat heart ventricle during morphine dependence. Involvement of alpha(1)- and alpha(2)-adrenoceptors. Eur J Pharmacol. 2000;397:311–18.
   Google Scholar
• Dambisya YM, Wong CL, Chan K. Effects of sympathomimetic agents on opiate analgesia, tolerance and dependence in mice. Methods Find Exp Clin Pharmacol. 1991;13:239–48.
   Google Scholar
• Sierralta F, Naquira D, Pinardi G, Miranda HF. Alpha-adrenoceptor and opioid receptor modulation of clonidine-induced antinociception. Br J Pharmacol. 1996;119:551–4.
   Google Scholar
• Way EL, Loh HH, Shen FH. Simultaneous quantitative assessment of morphine tolerance and physical dependence. J Pharmacol Exp Ther. 1969;167:1–8.
   PubMed Web of Science ®Google Scholar
• Kanaan SA, Saade NE, Haddad JJ, Abdelnoor AM, Atweh SF, Jabbur SJ, Endotoxin-induced local inflammation and hyperalgesia in rats mince, a new model for inflammatory pain. Pharmacology. 1996;66:373–9.
   Google Scholar
• Ramabadran K, Bansinath M, Turndorf H, Puig MM. The hyperalgesic effect of naloxone is attenuated in streptozotocin-diabetic mice. Psychopharmacology (Berl). 1989;97:169–74.
   PubMedGoogle Scholar
• Christie MJ, Williams JT, North RA. Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol Pharmacol. 1987;32:633–8.
   Google Scholar
• Bryant CD, Eitan S, Sinchak K, Fanselow MS, Evans CJ. NMDA receptor antagonism disrupts the development of morphine analgesic tolerance in male, but not female C57BL/6J mice. Am J Physiol Regul Integr Comp Physiol. 2006;291:315–26.
   PubMed Web of Science ®Google Scholar
• Furst S. Transmitters involved in antinociception in the spinal cord. Brain Res Bull. 1999;48:129–41.
   PubMed Web of Science ®Google Scholar
• Summers RJ, McMartin LR. Adrenoceptors and their second messenger systems. J Neurochem. 1993;60:10–23.
   Google Scholar
• Sagen J, Proudfit HK. Evidence for pain modulation by pre- and postsynaptic noradrenergic receptors in the medulla oblongata. Brain Res. 1985;331:285–93.
   PubMed Web of Science ®Google Scholar
• Brenner GM, Klopp AJ, Deason LL, Stevens CW. Analgesic potency of alpha adrenergic agents after systemic administration in amphibians. J Pharmacol Exp Ther. 1994;270:540–5.
   Google Scholar
• Holden JE, Schwartz EJ, Proudfit HK. Microinjection of morphine in the A7 catecholamine cell group produces opposing effects on nociception that are mediated by alpha1- and alpha 2-adrenoceptors. Neuroscience. 1999;91:979–90.
   Google Scholar
• Proudfit HK, Monsen M. Ultrastructural evidence that substance P neurons form synapses with noradrenergic neurons in the A7 catecholamine cell group that modulate nociception. Neuroscience. 1999;91:1499–513.
   Google Scholar
• Belgrade M, Hall S. Dexmedetomidine infusion for the management of opioid-induced hyperalgesia. Pain Med. 2010;11:1819–26.
   PubMed Web of Science ®Google Scholar
• Hedo G, Lopez-Garcia JA. Alpha-1A adrenoceptors modulate potentiation of spinal nociceptive pathways in the rat spinal cord in vitro. Neuropharmacology. 2001;41:862–9.
   Google Scholar
• Wada T, Hasegawa Y, Ono H. Characterization of alpha1-adrenoceptor subtypes in facilitation of rat spinal motoneuron activity. Eur J Pharmacol. 1997;340:45–52.
   PubMedGoogle Scholar
• Fairbanks CA, Stone LS, Kitto KF, Nguyen HO, Posthumus IJ, Wilcox GL. Alpha(2C)-adrenergic receptors mediate spinal analgesia and adrenergic–opioid synergy. J Pharmacol Exp Ther. 2002;300:282–90.
   PubMed Web of Science ®Google Scholar
• Bohn LM, Xu F, Gainetdinov RR, Caron MG. Potentiated opioid analgesia in norepinephrine transporter knock-out mice. J Neurosci. 2000;20:9040–5.
   Google Scholar
• Rossetti ZL, Longu G, Mercuro G, Gessa GL. Extraneuronal noradrenaline in the prefrontal cortex of morphine-dependent rats: tolerance and withdrawal mechanisms. Brain Res. 1993;609:316–20.
   Google Scholar
• Tekol Y, Tercan E, Esmaoglu A. Ephedrine enhances analgesic effect of morphine. Acta Anaesthesiol Scand. 1994;38:396–7.
   Google Scholar
• Taylor DA, Fleming WW. Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther. 2001;297:11–18.
   PubMed Web of Science ®Google Scholar
• Tsao PI, von Zastrow M. Diversity and specificity in the regulated endocytic membrane trafficking of G-protein-coupled receptors. Pharmacol Ther. 2001;89:139–47.
   Google Scholar
• Nestler EJ, Aghajanian K. Molecular and cellular basis of addiction. Science. 1997;278:58–63.
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Berhow MT, Brodkin ES. Molecular mechanisms of drug addiction: adaptations in signal transduction pathways. Mol Psychiatry. 1996;1:190–9.
   PubMed Web of Science ®Google Scholar
• Bohn LM, Lefkowitz RJ, Caron MG. Differential mechanisms of morphine antinociceptive tolerance revealed in (beta) arrestin-2 knock-out mice. J Neurosci. 2002;22:10494–500.
   PubMed Web of Science ®Google Scholar